Drug Trial Radar · NCT03364153
Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)
Last checked: Nov 20, 2026Latest source record: Apr 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
121
Actual
Start
Jan 12, 2018
Primary completion
Mar 31, 2025
Study completion Mar 31, 2025
Sponsor
- Lead sponsor
- Astellas Pharma Global Development, Inc.Astellas (ALPMY)
- Sponsor type
- Industry
- First posted
- Dec 6, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of avacincaptad pegol intravitreal injection compared to Sham in participants with autosomal recessive Stargardt disease 1 (STGD1).
Conditions
- Stargardt's Macular Dystrophy
Interventions
avacincaptad pegolDrug
Intravitreal Injection
ShamDrug
Intravitreal Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Rate of Change in the Area of Ellipsoid Zone Defect From Baseline Through Month 18Time frame: Baseline to Month 18
Locations
41 sites in 8 countries. Site status is shown where the registry gives one.
Retinal Research Institute
Phoenix, Arizona
Jules Stein Eye Institute/ David Geffen School of Medicine
Los Angeles, California
VitreoRetinal Associates
Gainesville, Florida
Retina Specialty Institute
Pensacola, Florida
Wilmer Eye Institute, Johns Hopkins
Baltimore, Maryland
Ophthalmic Consultants of Boston
Boston, Massachusetts
University of Michigan/Kellogg Eye Center
Ann Arbor, Michigan
The Retina Center
Minneapolis, Minnesota
Retina Center of NJ, LLC.
Bloomfield, New Jersey
Casey Eye Institute/Oregon Health & Science University
Portland, Oregon
Wills Eye Hospital/Mid Atlantic Retina
Philadelphia, Pennsylvania
UPMC Eye Center
Pittsburgh, Pennsylvania
Palmetto Retina Center
West Columbia, South Carolina
Austin Retina Associates
Austin, Texas
Retina Foundation of the Southwest
Dallas, Texas
Strategic Clinical Research Group
Willow Park, Texas
University of Utah John A. Moran Eye Center
Salt Lake City, Utah
Creteil University Eye Clinic University Paris EST
Créteil, France
Centre ophtalmologique des Quinzes Vingts
Paris, France
Hopital de la Croix-Rousse
Lyon, Auvergne-Rhône-Alpes, France
University of Bonn
Bonn, Germany
Augenklinik der LMU München
München, Germany
University of Tuebingen
Tübingen, Germany
Budapest Retina Institute
Budapest, Hungary
Semmelweis Egyetem
Budapest, Hungary
University of Debrecen DE KK Szemészeti Klinika
Debrecen, Hungary
Ganglion Medical Center
Pécs, Hungary
Szegedi Tudomanyegyetem, Szent-Gyorgyi Albert Klinikai Kozpont, Szemeszeti Klinika
Szeged, Hungary
Rambam Health Care Campus
Haifa, Israel
Hadassah University Hospital
Jerusalem, Israel
Rabin Medical Center, Beilinson campus
Petah Tikva, Israel
Kaplan Medical Center
Rehovot, Israel
Tel-Aviv Sourasky Medical Center, Ichilov Hospital
Tel Aviv, Israel
AOU Policlinico Sant'Orsola Malpighi, U.O. Oftalmologia,
Bologna, Italy
Azienda Ospedaliera Universitaria Careggi
Florence, Italy
Ospedale San Raffaele
Milan, Italy
University of Campania Luigi Vanvitelli Eye Clinic
Naples, Italy
Fondazione Policlinico Tor Vergata, UOSD Patologie Retiniche
Rome, Italy
Institut de la Macula
Barcelona, Spain
Princess Alexandra Eye Pavillion
Edinburgh, United Kingdom
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.